Association with PD-L1 Expression and Clinicopathological Features in 1000 Lung Cancers: A Large Single-Institution Study of Surgically Resected Lung Cancers with a High Prevalence of EGFR Mutation

Programmed cell death ligand 1 (PD-L1) expression is an important biomarker for predicting response to immunotherapy in clinical practice. Hence, identification and characterization of factors that predict high expression of PD-L1 in patients is critical. Various studies have reported the associatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung Eun, Kim, Yu Jin, Sung, Minjung, Lee, Mi-Sook, Han, Joungho, Kim, Hong Kwan, Choi, Yoon-La
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801455/
https://www.ncbi.nlm.nih.gov/pubmed/31561631
http://dx.doi.org/10.3390/ijms20194794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801455/
https://www.ncbi.nlm.nih.gov/pubmed/31561631
http://dx.doi.org/10.3390/ijms20194794

Ejemplares similares